Eleftherios Mylonakis, MD and Panayiotis D. Ziakas, MD, MSc, PhD
Allocating resources for interventions requires consensus among stakeholders with a plurality of perspectives about how to weigh antimicrobial stewardship interventions’ risks and benefits.
AMA J Ethics. 2021;23(8):E631-638. doi:
10.1001/amajethics.2021.631.
When symptoms of polypharmacy are consistent with those of difficult-to-diagnose disorders, reliable determinations about which drugs are necessary is critical.
AMA J Ethics. 2018;20(12):E1133-1138. doi:
10.1001/amajethics.2018.1133.
Dr Jo Ellen Wilson joins Ethics Talk to discuss her article, coauthored with Drs Jennifer M. Connell and Maria C. Duggan: “Why We Must Prevent and Appropriately Manage Delirium.”
This case invites us to think about the real and potential risks that surgeons pose to patients. The risk of HIV acquisition from an infected surgeon appears much lower than the risk of nosocomial bacterial infections, even those with lethal potential.
Primary materials including interviews with some of the volunteer subjects provide information on the experiments into the pathogenic mechanism of yellow fever.
Lloyd Duplechan joins Ethics Talk to discuss health organizations’ responsibilities to protect employees and community members from antimicrobial resistance.
Alysse Gail Wurcel, MD, MS, Jacinda C. Abdul-Mutakabbir, PharmD, MPH, Shira Doron, MD, Christina Yen, MD, and Justin Berk, MD, MPH, MBA
Antimicrobial resistance is a global threat that inequitably affects minoritized populations, including Black, Latinx, and Indigenous people, especially in carceral settings.
AMA J Ethics. 2024;26(5):E399-407. doi:
10.1001/amajethics.2024.399.